| SFDA Approved Use |
lomitapide is intended for the following indications:as an adjunct to a low-fat diet and other lipid-lowering medicinal products with or without low density lipoprotein (LDL) apheresis for the treatment of adult and paediatric patients aged 5 years and older with homozygous familial hypercholesterolemia (HoFH). |
|---|
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
Beta version
Official Saudi government website domains end with gov.sa
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Official Reliable websites use HTTPS
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.